Author:
Gansner John M.,Berliner Nancy
Publisher
Springer International Publishing
Reference54 articles.
1. Ang EY, Ang YN, Soh JY, Liew WK, Chan KW, Thoon KC, et al. Reliability of acute illness dihydrorhodamine-123 testing for chronic granulomatous disease. Clin Lab. 2013;59(1–2):203–6.
2. Antunes H, Pereira Â, Cunha I. Chediak-Higashi syndrome: pathognomonic feature. Lancet. 2013;382(9903):1514.
3. Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968;278(18):971–6.
4. Baldus M, Zunftmeister V, Geibel-Werle G, Claus B, Mewes D, Uppenkamp M, et al. Chédiak-Higashi-Steinbrinck syndrome (CHS) in a 27-year-old woman – effects of G-CSF treatment. Ann Hematol. 1999;78(7):321–7.
5. Beauté J, Obenga G, Le Mignot L, Mahlaoui N, Bougnoux M-E, Mouy R, et al. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France. Pediatr Infect Dis J. 2011;30(1):57–62.